Analyst Ratings For Valeant Pharmaceuticals International (NYSE:VRX)
Today, BMO Capital Markets reiterated its Hold rating on Valeant Pharmaceuticals International (NYSE:VRX) with a price target of $15.00.
There are 3 sell ratings, 12 hold ratings, 4 buy ratings on the stock.
The current consensus rating on Valeant Pharmaceuticals International (NYSE:VRX) is Hold (Score: 2.05) with a consensus target price of $16.89 per share, a potential 4.93% downside.
Some recent analyst ratings include
- 7/27/2017-BMO Capital Markets Reiterated Rating of Hold.
- 7/17/2017-Stifel Nicolaus Reiterated Rating of Buy.
- 7/14/2017-Jefferies Group LLC Reiterated Rating of Buy.
- 7/14/2017-Wells Fargo & Company Reiterated Rating of Sell.
- 7/14/2017-Piper Jaffray Companies Reiterated Rating of Underweight.
Recent Insider Trading Activity For Valeant Pharmaceuticals International (NYSE:VRX)
Valeant Pharmaceuticals International (NYSE:VRX) has insider ownership of 5.87% and institutional ownership of 50.42%.
- On 5/11/2017 Schutter Richard U De, Director, bought 20,000 with an average share price of $13.90 per share and the total transaction amounting to $278,000.00. View SEC Filing
- On 3/15/2017 Schutter Richard U De, Director, bought 10,000 with an average share price of $10.80 per share and the total transaction amounting to $108,000.00. View SEC Filing
- On 3/14/2017 Paul Herendeen, CFO, bought 24,000 with an average share price of $10.72 per share and the total transaction amounting to $257,280.00. View SEC Filing
- On 3/14/2017 Valueact Capital Master Fund,, Insider, bought 3,000,000 with an average share price of $10.82 per share and the total transaction amounting to $32,460,000.00. View SEC Filing
- On 3/13/2017 Pershing Square Capital Manage, Director, sold 18,114,432 with an average share price of $11.00 per share and the total transaction amounting to $199,258,752.00. View SEC Filing
- On 12/14/2016 Thomas W Sr. Ross, Director, bought 5,000 with an average share price of $14.73 per share and the total transaction amounting to $73,650.00. View SEC Filing
- On 12/12/2016 Pershing Square Capital Manage, Director, sold 3,476,690 with an average share price of $14.85 per share and the total transaction amounting to $51,628,846.50. View SEC Filing
Recent Trading Activity for Valeant Pharmaceuticals International (NYSE:VRX)
Shares of Valeant Pharmaceuticals International closed the previous trading session at 17.77 up +0.06 0.34% with 9,316,527 shares trading hands.